About Us
Management Team
Board of Directors
Investors
Careers
About Us | MANAGEMENT TEAM
Susan M. Molineaux, Ph.D.
President and Chief Executive Officer
Dr. Molineaux is a co-founder of Calithera Biosciences and has served as the company’s Chief Executive Officer since the company’s founding in June 2010. Dr. Molineaux was most recently a founder, CSO and CEO of Proteolix, a company that discovered and developed proteasome inhibitors for the treatment of cancer and autoimmune disease. Prior to joining Proteolix, Dr. Molineaux was Vice President, Biology at Rigel Pharmaceuticals from 2000 to 2003. Before that, she was Vice President, Biology at Praelux, and from 1994 through 1999, Dr. Molineaux served as Vice President of Drug Development at Praecis Pharmaceuticals. From 1989 until 1994 she was a scientist in the Immunology group at Merck, in Rahway, NJ. Dr. Molineaux received a B.S. degree in Biology from Smith College, a Ph.D. degree in Molecular Biology from Johns Hopkins University, and completed a postdoctoral fellowship at Columbia University.
Mark K. Bennett, Ph.D.
Senior Vice President, Research
Dr. Bennett has served as the Senior Vice President of Research at Calithera Biosciences since the company’s founding in June 2010. Prior to joining Calithera, Dr. Bennett was at Proteolix in South San Francisco, CA from 2003 to 2009, serving as the Vice President of Research from 2006 to 2009 and as Director of Biological Research, from the company’s founding in 2003 through 2005. Prior to joining Proteolix, Dr. Bennett was Director of Cell Biology at Rigel Pharmaceuticals in South San Francisco, CA from 1999 to 2003. From 1993 through 1999, Dr. Bennett was an Assistant Professor in the Department of Molecular and Cell Biology at the University of California, Berkeley. Dr. Bennett received a B.S. degree in Biochemistry and Biophysics from Oregon State University, a Ph.D. degree in Neuroscience from the California Institute of Technology, and completed postdoctoral fellowships at the European Molecular Biology Laboratory and Stanford University.
Eric Sjogren, Ph.D.
Sr. Vice President, Drug Discovery
Dr. Sjogren has served as the Senior Vice President of Drug Discovery at Calithera Biosciences since the company’s founding in June 2010. Dr. Sjogren has over 20 years of experience in the pharmaceutical industry, starting with Syntex in1986 and continuing with Roche. Prior to joining Calithera, Dr. Sjogren was Vice President and Head of Medicinal Chemistry at Roche Palo Alto LLC, where he directed small molecule drug discovery in the areas of inflammation, virology, and CNS. Dr. Sjogren received a B.A. degree in Chemistry from the University of California, San Diego and a Ph.D. degree in Chemistry from Harvard University.
Susan M. Molineaux, Ph.D.
President and Chief Executive Officer
Dr. Molineaux is a co-founder of Calithera Biosciences and has served as the company’s Chief Executive Officer since the company’s founding in June 2010. Dr. Molineaux was most recently a founder, CSO and CEO of Proteolix, a company that discovered and developed proteasome inhibitors for the treatment of cancer and autoimmune disease. Prior to joining Proteolix, Dr. Molineaux was Vice President, Biology at Rigel Pharmaceuticals from 2000 to 2003. Before that, she was Vice President, Biology at Praelux, and from 1994 through 1999, Dr. Molineaux served as Vice President of Drug Development at Praecis Pharmaceuticals. From 1989 until 1994 she was a scientist in the Immunology group at Merck, in Rahway, NJ. Dr. Molineaux received a B.S. degree in Biology from Smith College, a Ph.D. degree in Molecular Biology from Johns Hopkins University, and completed a postdoctoral fellowship at Columbia University.
Mark K. Bennett, Ph.D.
Senior Vice President, Research
Dr. Bennett has served as the Senior Vice President of Research at Calithera Biosciences since the company’s founding in June 2010. Prior to joining Calithera, Dr. Bennett was at Proteolix in South San Francisco, CA from 2003 to 2009, serving as the Vice President of Research from 2006 to 2009 and as Director of Biological Research, from the company’s founding in 2003 through 2005. Prior to joining Proteolix, Dr. Bennett was Director of Cell Biology at Rigel Pharmaceuticals in South San Francisco, CA from 1999 to 2003. From 1993 through 1999, Dr. Bennett was an Assistant Professor in the Department of Molecular and Cell Biology at the University of California, Berkeley. Dr. Bennett received a B.S. degree in Biochemistry and Biophysics from Oregon State University, a Ph.D. degree in Neuroscience from the California Institute of Technology, and completed postdoctoral fellowships at the European Molecular Biology Laboratory and Stanford University.
Eric Sjogren, Ph.D.
Sr. Vice President, Drug Discovery
Dr. Sjogren has served as the Senior Vice President of Drug Discovery at Calithera Biosciences since the company’s founding in June 2010. Dr. Sjogren has over 20 years of experience in the pharmaceutical industry, starting with Syntex in1986 and continuing with Roche. Prior to joining Calithera, Dr. Sjogren was Vice President and Head of Medicinal Chemistry at Roche Palo Alto LLC, where he directed small molecule drug discovery in the areas of inflammation, virology, and CNS. Dr. Sjogren received a B.A. degree in Chemistry from the University of California, San Diego and a Ph.D. degree in Chemistry from Harvard University.